Authors:
LEBEAU B
DEPIERRE A
GIOVANNINI M
RIVIERE A
KALUZINSKI L
VOTAN B
HEDOUIN M
DALLENS H
AUBIER M
BACHAUD JM
BALMES P
BERNARD JP
BIRON E
BONNAUD F
BONSROSSET F
BOUFFETTE P
BOYER J
BRUNET R
CAILLAUD D
CALAIS G
CAPDEVILLE J
CATRYTHOMAS I
CHAUMIER P
CHAVAILLON JM
CHEVALLIER B
CLAVIER J
CONSTANS P
CUPISSOL D
DAVID P
DELZENNE A
DERENNE JP
ESCAMILLA R
EYMARD JC
FABBRO M
FABRE V
FAYOLLE V
FOURNEL P
FRANCHI C
FRUGE I
GUERIN JC
GOUEROU H
HADJADJ D
KELKEL E
LACROIX H
LEBOURGEOIS JP
LEBRUN D
LUCAS P
MARTIN M
MARTY M
MATHIEU JP
MEURISSE MP
MITAL P
MORO D
MUIR JF
ORFEUVRE H
PERPOINT B
QUOIX E
REBISCHUNG JL
REBOULET V
RIOU R
SALTIEL JC
SLAWINSKI JC
SEVIN D
TAULELLE M
TUBIANA N
VOLOCH A
WEITZENBLUM E
ZYLBERBERG R
Citation: B. Lebeau et al., THE EFFICACY OF A COMBINATION OF ONDANSETRON, METHYLPREDNISOLONE AND METOPIMAZINE IN PATIENTS PREVIOUSLY UNCONTROLLED WITH A DUAL ANTIEMETIC TREATMENT IN CISPLATIN-BASED CHEMOTHERAPY, Annals of oncology, 8(9), 1997, pp. 887-892
Authors:
MOSNIER JF
PERRET AG
VINDIMIAN M
DUMOLLARD JM
BALIQUE JG
PERPOINT B
BOUCHERON S
Citation: Jf. Mosnier et al., AN IMMUNOHISTOCHEMICAL STUDY OF THE SIMULTANEOUS EXPRESSION OF BCL-2 AND P53 ONCOPROTEINS IN EPITHELIAL TUMORS OF THE COLON AND RECTUM, Archives of pathology and laboratory medicine, 120(7), 1996, pp. 654-659
Authors:
PERPOINT B
LEBOUSSEKERDILES C
CLAY D
SMADJAJOFFE F
DEPRESBRUMMER P
LAPORTESIMITSIDIS S
JASMIN C
LEVI F
Citation: B. Perpoint et al., IN-VITRO CHRONOPHARMACOLOGY OF RECOMBINANT MOUSE IL-3, MOUSE GM-CSF, AND HUMAN G-CSF ON MURINE MYELOID PROGENITOR CELLS, Experimental hematology, 23(4), 1995, pp. 362-368
Authors:
LEVI FA
ZIDANI R
VANNETZEL JM
PERPOINT B
FOCAN C
FAGGIUOLO R
CHOLLET P
GARUFI C
ITZHAKI M
DOGLIOTTI L
IACOBELLI S
ADAM R
KUNSTLINGER F
GASTIABURU J
BISMUTH H
JASMIN C
MISSET JL
Citation: Fa. Levi et al., CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL, Journal of the National Cancer Institute, 86(21), 1994, pp. 1608-1617
Authors:
LEVI FA
ZIDANI R
VANNETZEL JM
PERPOINT B
FOCAN C
FAGGIUOLO R
CHOLLET P
GARUFI C
ITZHAKI M
DOGLIOTTI L
IACOBELLI S
ADAM R
KUNSTLINGER F
GASTIABURU J
BISMUTH H
JASMIN C
MISSET JL
Citation: Fa. Levi et al., CHRONOMODULATED VERSUS FIXED-INFUSION-RATE DELIVERY OF AMBULATORY CHEMOTHERAPY WITH OXALIPLATIN, FLUOROURACIL, AND FOLINIC ACID (LEUCOVORIN) IN PATIENTS WITH COLORECTAL-CANCER METASTASES - A RANDOMIZED MULTIINSTITUTIONAL TRIAL, Journal of the National Cancer Institute, 86(21), 1994, pp. 1608-1617
Authors:
PERPOINT B
MISMETTI P
SIMITSIDIS S
HOCQUART J
RAMBAUD C
BUCHMULLER A
QUENEAU P
DECOUSUS H
Citation: B. Perpoint et al., DOSING TIME OPTIMIZES SUSTAINED-RELEASE KETOPROFEN TREATMENT OF OSTEOARTHRITIS, Chronobiology international, 11(2), 1994, pp. 119-125
Authors:
ANSHELEVICH M
BOISSEL JP
DEBACKER G
KORNITZER M
LEIZOROVICZ A
MARZILLI M
VARSHAVSKY S
BEAUFILS P
MEINERTZ T
BRUN C
CHAUVIN F
CHERIEF A
CUCHERAT M
GAUTHIER E
GAYDAROVA M
GELASDORE C
GUENANECHE F
HAUGH MC
LION L
MAUPAS J
MERCIER C
PERRIN S
VISELE N
ANDREFOUET X
FINET G
PAGE Y
PERPOINT B
VITALDURAND D
DESCOTES J
SAPORI JM
PEETERMANS C
GUY JM
FRUCHAUD J
JARRY G
QUIRET JC
DURUP F
JOUANNON C
THANH XT
VEYRE B
MADIGNIER M
OLLIVIER L
CARCASSONE CH
BARADAT G
DUGRAND P
DAMBRINE P
GABRIEL A
LABAKI F
AMMOR M
GALLEY D
AUBERGER R
CAVALLARO J
BICKERT P
DESHAYES P
LOIRE J
BIETH A
DICKELE MC
FELLINGER F
MERMET P
RABATEL J
RAUFAST D
SOMMER A
CASTELLA N
LEFEVRE T
LOIRET J
ALLAM S
BERTHOU JD
KONING R
LETAC B
GALLET M
LOPEZ M
CONSTANS R
LEYMARIE JL
MOUYSSET B
MARTELET M
HADDAD J
DUJARDIN JJ
JOLY P
MARINA D
BERZIN B
PELISSET E
KARAM C
MICHELON G
SIBILLE JP
GULLY C
CASTAIGNE A
SAAL JP
VERCHUREN P
HEILIGENSTEIN D
SIBONI G
BROCHET E
MOULINIER L
VALERE PE
CHEIKEL J
JANINMANIFICAT L
SOCOLOVSKY C
BRAGARD MF
BOURDON JL
VINE F
HOUPLON M
PEROT M
ROUX JJ
SEBASTIEN P
DHAUTEFEUILLLE B
MYCINSKI C
MOSSAZ R
DIADEMA B
ESCANDE M
VIDAL P
CHAPON C
SABOYE JP
VIALLET M
BOURRAT M
BAUDET M
DEMARCQ JM
DENNETIERE S
HAFTEL Y
REBEIX G
GAUTHIER J
LEROY O
SANTRE C
BOURREUX C
LAYRE JC
DELYFERIAN P
JOUVE B
TOUSSAINT C
VEYRAT A
CORNAERT P
DUTOIT A
GERIN JF
BELTRAN J
GRELLET C
BARRAINE R
COISNE D
PALCOUX MC
GAILLEMIN C
NORMAND JP
SCHWOB J
FICHTER P
GRAND A
HURET JF
BEAUFFIGEAU A
MILANDOU A
RAKOTO D
COLPART E
LEPRINCE JL
ACAR J
MARONI JP
MENTRE B
MORIZOT D
CONTIN B
BENSLIMAN A
KETELERS JY
MOUAWAD W
FAITH R
TAVERNIER D
FOURNIER C
RINALDI JP
TERRAL A
DETURCK R
CAUSERET H
RICHARD C
HERMANN J
ELCADI T
SELLAL J
UBRICH M
HESSEL F
ACHEPAPILLON C
ESTAMPES B
FATAUD F
MATAGRIN C
BESSEDE G
YERETZIAN JC
DELEPORTE G
BERLEMONT D
RIFAI A
DEROUBAIX G
DELELIS P
LEFEBVRE JM
BAKHS G
POKROVSKAIA I
SHATALIN A
SZELIANSKAIA B
KOSTENKO V
BOIARKIN M
RUKSIN V
INIUSHIN A
SOROKIN L
GOLOSCHEKIN B
VISHNEVSKY A
KATASONOV V
EGOROVA E
IRKLIENKO K
ELALLAF D
MAMAAR R
DELANNAY G
ABRAMOWICZ M
BARTHELS M
LIGNIAN H
CAILLEAU S
FAUTSCH G
QUINONEZ M
LEONE A
STREULENS Y
DAUNE M
PICART N
DEVRIENDT J
TELERMAN M
BERGEZ B
CLEMENT DL
VANDERMERSCH C
BERGEN JM
FRANCOIS B
KLUYSKENS Y
BLOCK P
HUYGENS L
BEYS J
BOSSAERT L
DEMEY H
DENDOOVEN D
BLADT D
DIERICKX S
ROBBENS E
CARPEGGIANI C
BERNARDI D
GALATI A
BINI A
DELCITERNA F
IERI A
STEPHINGER U
Citation: M. Anshelevich et al., THE ESPRIM TRIAL - SHORT-TERM TREATMENT OF ACUTE MYOCARDIAL-INFARCTION WITH MOLSIDOMINE, Lancet, 344(8915), 1994, pp. 91-97